Concepedia

Bhakti Arondekar

BA

32

Publications

1.3K

Citations

20

H-Index

2002

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

Pfizer (United States)

Kaiser Permanente Center for Health Research

Optum (United States)

Emory University

Bhakti Arondekar is an author at GlaxoSmithKline (United States) specializing in health policy, diabetes, and medicine.

Top concepts

Health PolicyDiabetesMedicinePublic HealthHealth EconomicsMetabolic SyndromeObesityPsychiatryHyperglycemiaOutcomes Research

Publications per year

2002–2024

32

Publications

32

Diabetes Risk Calculator

K. E. Heikes, David M. Eddy, Bhakti Arondekar et al. · Diabetes Care · 2008 · 298 citations · Full text

Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population

Stephen J. Freedland, Matthew M. Davis, Andrew J. Epstein et al. · Prostate Cancer and Prostatic Diseases · 2023 · 90 citations · Full text

Psychometric Evaluation of the Diabetes Symptom Checklist-Revised (DSC-R)—A Measure of Symptom Distress

Robert Arbuckle, L. Humphrey, K Vardeva et al. · Value in Health · 2009 · 84 citations · Full text

Diabetes Symptom, Diabetes Management, Psychiatry +9

Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia

Jennifer Christian, Bhakti Arondekar, Erin Buysman et al. · Journal of clinical lipidology · 2012 · 76 citations

Metabolic Syndrome, Severe Hypertriglyceridemia, Follow-up Triglyceride Levels +11

Determining Triglyceride Reductions Needed for Clinical Impact in Severe Hypertriglyceridemia

Jennifer Christian, Bhakti Arondekar, Erin Buysman et al. · The American Journal of Medicine · 2013 · 74 citations

Obesity, Metabolic Syndrome, Cardiovascular Disease +11

Rows per page

1–5 of 32